|
Genetic testing provides valuable diagnostic and prognostic information about disease risk factors and carrier status that are often important in patient management decisions.
- Cystic Fibrosis 32 Mutation Analysis Panel [CF]
- Cystic Fibrosis Intron 8 5T/7T/9T Mutation Analysis [CF 5T]
- Factor II Prothrombin G20210A [F2PRO]
- Factor V Leiden R506Q [FVLEI]
- Methylenetetrahydrofolate Reductase A1298C [MTHFR 1298]
- Methylenetetrahydrofolate Reductase C677T [MTHFR 677]
The CF carrier panel we offer exceeds the American College of Medical Genetics CF screening guidelines. In addition, our ThromboFLEX Profile simultaneously analyzes the Factor V, Factor II and MTHFR genes.
|
